Eledon Pharmaceuticals Inc (ELDN) — Cash Flow Quality Index
Latest as of September 2024:
-0.18x
Eledon Pharmaceuticals Inc (ELDN) has a Cash Flow Quality Index of -0.18x as of September 2024. Operating cash flow of $-11.77 Million is below net income of $63.63 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore Eledon Pharmaceuticals Inc (ELDN) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
-0.18x
Operating CF / Net Income
Operating Cash Flow
$-11.77 Million
USD
Net Income
$63.63 Million
USD
Data as of
Sep 2024
Most recent filing
Annual Cash Flow Quality Index for Eledon Pharmaceuticals Inc (None–None)
Year-by-year earnings quality comparison for Eledon Pharmaceuticals Inc. For live market cap and the full company financial profile, see ELDN stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.